India  

European Medicines Agency issues post-vax adverse-event alert for medics

IndiaTimes Sunday, 11 April 2021
The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical professionals to look out for cases of unusual blood clots with low platelets, a rare adverse event with the vaccine.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

European Medicines Agency European Medicines Agency Agency of the European Union

Europe soon open to vaccinated Americans -official [Video]

Europe soon open to vaccinated Americans -official

A top European Union official said Sunday that Americans who have been vaccinated against COVID-19 should be able to travel to Europe by summer, easing existing travel restrictions. Bryan Wood reports.

Credit: Reuters - Politics    Duration: 01:03Published
Europe's week: AstraZeneca jab troubles and Turkey's diplomacy mistake [Video]

Europe's week: AstraZeneca jab troubles and Turkey's diplomacy mistake

The European Medicines Agency said the Oxford/AstraZeneca vaccine could potentially cause rare blood clots and Commission President von der Leyen got sidelined in Ankara. Here's a look at two key stories making the news in Brussels this week.

Credit: Euronews English    Duration: 07:00Published
Janssen vaccine has 'possible link' to blood clots, says European regulator [Video]

Janssen vaccine has 'possible link' to blood clots, says European regulator

There is a “possible link” between Johnson & Johnson’s Covid-19 vaccine and very rare blood clots, the European medicines regulator has said.But the European Medicines Agency (EMA) concluded the overall benefits of the vaccine “outweigh the risks of side effects”.The Janssen vaccine is yet to be approved for use in the UK.The safety committee of the EMA concluded that unusual blood clots with low blood platelets should be listed as a “very rare” side effect of the vaccine.

Credit: PA - Press Association STUDIO    Duration: 01:39Published
EMA: Benefits of AstraZeneca jab outweigh risks [Video]

EMA: Benefits of AstraZeneca jab outweigh risks

Emer Cooke, executive director of the EMA, says its review “confirmed that the benefits of the AstraZeneca vaccine in preventing Covid-19 overall outweigh the risk of side effects”.Ms Cooke added: “Vaccination is extremely important in helping us in the fight against Covid-19.”

Credit: PA - Press Association STUDIO    Duration: 01:35Published
Fauci says U.S. may not need AstraZeneca vaccine [Video]

Fauci says U.S. may not need AstraZeneca vaccine

The United States may not need AstraZeneca's COVID-19 vaccine, even if it wins U.S. regulatory approval, Anthony Fauci, the nation's top infectious disease doctor told Reuters on Thursday.

Credit: Reuters - Politics    Duration: 01:01Published

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Bleeding, clotting events post COVID vaccination 'minuscule' in India: Govt panel

India has reported 26 potential cases of bleeding and clotting after the administration of Covishield vaccine.
DNA

New Covishield schedule of 12-16 wks in CoWin

The government has reconfigured the CoWin platform to reflect the new dosing schedule of 12-16 weeks for Covishield as against the previous scheme where..
IndiaTimes

CoWIN reconfigured: Covishield second dose appointment after 84 days, existing booking to remain valid

CoWIN digital portal has been reconfigured to reflect changes in dose interval of Covishield vaccine to 12-16 weeks, said the Health Ministry.
DNA

Not cancelling existing online bookings for 2nd Covishield dose: Govt

The Union health ministry on Sunday clarified that all those people who had already booked online appointments for the second dose of Covishield vaccine will be..
IndiaTimes

Govt on increased gap in Covishield doses : ‘Driven by science’

While the UK has decided to shorten the gap between Covishield doses, the Centre stood by its decision to increase the gap, and said it was based on assessment..
IndiaTimes

AstraZeneca British-Swedish pharmaceutical company

Mixing Covid-19 vaccines 'could increase side effects' [Video]

Mixing Covid-19 vaccines 'could increase side effects'

Researchers from the Oxford Vaccine Group's Com-COV vaccine trial discovered that adults were more likely to suffer from mild to moderate side effects after mixing doses of the AstraZeneca and Pfizer jabs

Credit: Cover Video STUDIO    Duration: 01:22Published
Vaccine in numbers: More than 18 million second jabs given [Video]

Vaccine in numbers: More than 18 million second jabs given

More than 18 million second coronavirus jabs have been given in the UK, along with 35,587,348 first doses. The statistics come after protesters demanded that AstraZeneca share its Covid-19 vaccine technology, holding a noisy demonstration outside the pharmaceutical firm’s Cambridge headquarters.

Credit: PA - Press Association STUDIO    Duration: 00:37Published
European Union opts not to renew AstraZeneca vaccines contract after supply row [Video]

European Union opts not to renew AstraZeneca vaccines contract after supply row

Commissioner Thierry Breton says a post-June order has not been made as French President Emmanuel Macron says the bloc will focus on different vaccines

Credit: euronews (in English)    Duration: 01:00Published

You Might Like


Related videos from verified sources

EU medicines regulator approves new COVID-19 vaccine production sites [Video]

EU medicines regulator approves new COVID-19 vaccine production sites

The European Medicines Agency also greenlights more flexible storage conditions for Pfizer jabs as authorities across the continent struggle to ramp up vaccination.

Credit: Euronews English     Duration: 03:19Published

Related news from verified sources

DNA Explainer: Possible link between AstraZeneca vaccine and rare cases of blood clots

Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot.
DNA Also reported by •IndiaTimesIndian Express

European Medicines Agency issues post-vax adverse-event alert for medics

The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical...
IndiaTimes

'I don't want that': France struggles to pitch Oxford vaccine

Across the European Union, opinion polls and data from government vaccination programmes indicate a widespread scepticism about the AstraZeneca vaccine, rooted...
IndiaTimes